Nakanishi Past Earnings Performance

Past criteria checks 4/6

Nakanishi has been growing earnings at an average annual rate of 29.6%, while the Medical Equipment industry saw earnings growing at 6.7% annually. Revenues have been growing at an average rate of 14.6% per year. Nakanishi's return on equity is 17.5%, and it has net margins of 31.1%.

Key information

29.6%

Earnings growth rate

30.1%

EPS growth rate

Medical Equipment Industry Growth7.8%
Revenue growth rate14.6%
Return on equity17.5%
Net Margin31.1%
Next Earnings Update14 Nov 2024

Recent past performance updates

Recent updates

There Is A Reason Nakanishi Inc.'s (TSE:7716) Price Is Undemanding

Aug 29
There Is A Reason Nakanishi Inc.'s (TSE:7716) Price Is Undemanding

Nakanishi (TSE:7716) Will Pay A Dividend Of ¥26.00

Aug 11
Nakanishi (TSE:7716) Will Pay A Dividend Of ¥26.00

Nakanishi (TSE:7716) Has More To Do To Multiply In Value Going Forward

Aug 09
Nakanishi (TSE:7716) Has More To Do To Multiply In Value Going Forward

With EPS Growth And More, Nakanishi (TSE:7716) Makes An Interesting Case

Jun 20
With EPS Growth And More, Nakanishi (TSE:7716) Makes An Interesting Case

Nakanishi (TSE:7716) Has Announced A Dividend Of ¥26.00

Jun 02
Nakanishi (TSE:7716) Has Announced A Dividend Of ¥26.00

Is There An Opportunity With Nakanishi Inc.'s (TSE:7716) 25% Undervaluation?

May 28
Is There An Opportunity With Nakanishi Inc.'s (TSE:7716) 25% Undervaluation?

Nakanishi's (TSE:7716) Returns Have Hit A Wall

May 02
Nakanishi's (TSE:7716) Returns Have Hit A Wall

Here's Why Nakanishi (TSE:7716) Can Manage Its Debt Responsibly

Apr 03
Here's Why Nakanishi (TSE:7716) Can Manage Its Debt Responsibly

Does Nakanishi (TSE:7716) Deserve A Spot On Your Watchlist?

Mar 14
Does Nakanishi (TSE:7716) Deserve A Spot On Your Watchlist?

Revenue & Expenses Breakdown

How Nakanishi makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:7716 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2469,99021,75824,7380
31 Mar 2464,23622,90622,1280
31 Dec 2359,69222,83519,9240
30 Sep 2353,78824,64718,4180
30 Jun 2352,46813,82417,4140
31 Mar 2350,30512,63416,3100
31 Dec 2248,67112,47115,0050
30 Sep 2247,48812,21414,6750
30 Jun 2246,30511,48613,9310
31 Mar 2245,50110,17013,2530
31 Dec 2144,85710,10212,8450
30 Sep 2144,24310,65811,7060
30 Jun 2142,3809,96311,2850
31 Mar 2137,0969,08710,5140
31 Dec 2033,0556,45510,4710
30 Sep 2031,5886,10510,6830
30 Jun 2031,8535,93510,8860
31 Mar 2034,4455,93111,4640
31 Dec 1935,4187,10211,7270
30 Sep 1935,3156,41811,9920
30 Jun 1934,8976,25411,9050
31 Mar 1935,6167,32411,7360
31 Dec 1836,5437,58811,3450
30 Sep 1836,5908,26111,0950
30 Jun 1836,7918,40010,8130
31 Mar 1835,7567,55010,8900
31 Dec 1734,3417,34110,7340
30 Sep 1733,7696,38910,9940
30 Jun 1732,6726,03110,8970
31 Mar 1731,9745,66110,5800
31 Dec 1631,8295,29710,3100
30 Sep 1631,8675,7889,9190
30 Jun 1632,0505,6629,9360
31 Mar 1631,9445,8649,8620
31 Dec 1531,8626,2039,7720
30 Sep 1531,1866,2089,8730
30 Jun 1530,8386,9119,5940
31 Mar 1530,4466,9809,2910
31 Dec 1430,9086,9659,2440
30 Sep 1430,2046,2408,9280
30 Jun 1429,1475,5828,7130
31 Mar 1428,5065,2208,4340
31 Dec 1326,2364,7357,9870

Quality Earnings: 7716 has a large one-off gain of ¥11.6B impacting its last 12 months of financial results to 30th June, 2024.

Growing Profit Margin: 7716's current net profit margins (31.1%) are higher than last year (26.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 7716's earnings have grown significantly by 29.6% per year over the past 5 years.

Accelerating Growth: 7716's earnings growth over the past year (57.4%) exceeds its 5-year average (29.6% per year).

Earnings vs Industry: 7716 earnings growth over the past year (57.4%) exceeded the Medical Equipment industry 4.5%.


Return on Equity

High ROE: 7716's Return on Equity (17.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies